Drug Repurposing for Non-Alcoholic Fatty Liver Disease by Analyzing Networks Among Drugs, Diseases, and Genes
Background/Objectives: Drug development for complex diseases such as NAFLD is often lengthy and expensive. Drug repurposing, the process of finding new therapeutic uses for existing drugs, presents a promising alternative to traditional approaches. This study aims to identify potential repurposed dr...
Saved in:
| Main Authors: | Md. Altaf-Ul-Amin, Ahmad Kamal Nasution, Rumman Mahfujul Islam, Pei Gao, Naoaki Ono, Shigehiko Kanaya |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-04-01
|
| Series: | Metabolites |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-1989/15/4/255 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarker-driven drug repurposing for NAFLD-associated hepatocellular carcinoma using machine learning integrated ensemble feature selection
by: Subhajit Ghosh, et al.
Published: (2025-04-01) -
Co-Deposited Proteins in Alzheimer’s Disease as a Potential Treasure Trove for Drug Repurposing
by: Avgi E. Apostolakou, et al.
Published: (2025-04-01) -
VARIANTS AND PERSPECTIVES OF DRUG REPURPOSING FOR CANCER TREATMENT
by: A. V. Savinkova, et al.
Published: (2018-07-01) -
Repurposing Nitazoxanide for Potential Treatment of Rare Disease Lymphangioleiomyomatosis
by: Stella Bähr, et al.
Published: (2024-09-01) -
Drug repurposing: Clinical practices and regulatory pathways
by: K. Saranraj, et al.
Published: (2025-04-01)